Arthneeti

Neogen Chemicals Q1 FY27 Share Price & Earnings Call Analysis

₹2,261.70-0.41% today
Market cap
₹6,794 Cr
P/E
191.06
ROE
3.58%
PEG
-11.34
Price to sales
7.34
Debt to equity
1.71
52W high / low
₹2,688 / ₹980
Sales growth (5Y)
20.70%
EBITDA margin
16.64%
Net profit margin
3.34%
Promoter holding
48.31%
Sales (last year)
₹926 Cr

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

Guidance scorecard · Q1 FY27 call

What Neogen Chemicals Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

#20of 71 in
Chemicals & Petrochemicals
Revenue20–40%MarginsFlatCapexPlannedFundraisingPlannedOrder bookWhat management said

RevenueQ1 FY27 call

20–40%
  • Base business revenue expected to cross INR 1,000 crore in FY27 with 10-15% growth projected for FY28, targeting INR 1,100-1,200 crore.
  • Optimization focus in FY28 on margins, working capital, and product mix, emphasizing larger volume molecules to improve efficiency.
  • Battery chemicals business anticipated to reach INR 300 crore revenue in FY27, mainly from salts (~INR 200 crore) and electrolyte (~INR 100 crore).
  • FY28 battery chemicals revenue expected to exceed INR 1,000 crore with 70-80% salt utilization and 30-50% electrolyte utilization.
  • By FY29, full capacity utilization is targeted for both base and battery businesses, potentially generating INR 2,400-2,900 crore revenue from local electrolyte and international salt business.

2 more points from Neogen Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what Neogen Chemicals Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Neogen Ionics battery chemical CAPEX planned at INR 1,800 crore, with INR 1,300 crore already spent; remaining INR 500 crore expected by FY27 end.
  • Incremental CAPEX partly debt-funded and partly equity from Morita (around INR 40-50 crore equity remaining).
  • Additional CAPEX for salt and additive capacities planned: 2,000-ton salt capacity at Pakhajan and 500-ton additive capacity at Dahej, requiring ~15 months to build plus approvals.
  • Potential capacity ramp-up in organo-lithium segment with minor CAPEX (<INR 15 crore) expected in second half of current year after Board approval.
  • Future CSM business capacity expansion possible from FY29-FY30, post clarity on Dahej plant performance.

2 more points from Neogen Chemicals Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

Planned

See what Neogen Chemicals Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • The salt business for the current year is backed by long-term formula-based pricing contracts linked to lithium carbonate pricing, with firm orders already in place.
  • All four global customers have audited and approved Neogen's facility.
  • Customers are expected to start purchasing gradually in Q2 and Q3 FY27, with full supply from Neogen expected towards the end of Q3 and into Q4.

2 more points from Neogen Chemicals Ltd's call on the order book

Create a free account to keep reading this call

Full Q1 FY27 analysis
Full Chemicals & Petrochemicals ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Neogen Chemicals Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Sign up free to see every company in the sector ranking and track Neogen Chemicals Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Neogen Chemicals Ltd announcements

All announcements →

Financials of Neogen Chemicals Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Neogen Chemicals Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +204165162164200180193201203187209220247
Expenses +171137136144164149159167166155179188203
Operating Profit33282620363135353632303244
OPM %16%17%16%12%18%17%18%17%18%17%14%14%18%
Other Income +22222211-131221
Interest9111111101013131213192221
Depreciation4566677776778
Profit before tax2114116221615154145616
Tax %31%28%28%81%25%27%29%34%35%28%35%36%28%
Net Profit +141081171111102103411
EPS in Rs5.743.913.180.406.424.354.153.790.913.891.281.404.32

Financials of Neogen Chemicals Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +84100110161239306336487686691778862
Expenses +718690132196248272401575581641725
Operating Profit1314202943586487112110136137
OPM %15%14%18%18%18%19%19%18%16%16%18%16%
Other Income +1001101158-106
Interest558101212141929424875
Depreciation11123571216232828
Profit before tax8812172941445771535041
Tax %37%39%33%37%28%30%29%22%30%32%31%30%
Net Profit +558112129314550363529
EPS in Rs11.312.593.845.4910.4312.2813.4317.9020.0413.5113.2010.90
Dividend Payout %18%17%0%18%14%16%17%15%15%15%8%0%

Financials of Neogen Chemicals Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital42020202023232525262626
Reserves198223050133160414458734763790
Borrowings +242669821201372222293704095971,395
Other Liabilities +21264148566187131202292361691
Total Liabilities69801521802463554927991,0541,4611,7472,902
Fixed Assets +1317566783111127285347496404475
CWIP0111031151136109156857
Investments00001118277000
Other Assets +5562941121632412504225948561,1871,570
Total Assets69801521802463554927991,0541,4611,7472,902

Financials of Neogen Chemicals Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +99012-4-35841-30-29196-231
Cash from Investing Activity +-2-4-33-13-20-29-135-146-94-216-317-410
Cash from Financing Activity +-6-433-0246351188100237113642
Net Cash Flow101-10-1-044-25-8-8-0
Free Cash Flow74-33-1-24-63-51-65-134-332-121-647
CFO/OP89%83%21%55%4%-38%146%13%-17%-18%153%-154%

Financials of Neogen Chemicals Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days785810794939085829414994161
Inventory Days178190228192188257211258275365267445
Days Payable12013017714111171122131147138227346
Cash Conversion Cycle136117158145169276174209223376134260
Working Capital Days140126174486395661117912912385
ROCE %27%26%23%23%26%22%17%14%13%9%9%6%

Guidance history

How Neogen Chemicals Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%FlatPlannedPlanned—
Q4 FY26 call →20–40%FlatPlannedPlannedRising
Q3 FY26 call →10–20%FlatPlannedPlanned—
Q2 FY26 call →10–20%FlatPlannedPlanned—

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

85out of 100

Momentum score · price trend

85 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+55.3%86%
Last 6 months+38.1%84%
Last 3 months+13.8%83%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Neogen Chemicals Ltd: 0.4 × 86 + 0.4 × 84 + 0.2 × 83 = 85.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Neogen Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF Ltd